Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6904
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat ; volume:6 ; number:1 ; day:06 ; month:1 ; year:2006 ; pages:1-27 ; date:12.2006
BMC clinical pharmacology ; 6, Heft 1 (06.1.2006), 1-27, 12.2006
- Creator
-
Levitt, David G.
- Contributor
-
Schoemaker, Rik C.
SpringerLink (Online service)
- DOI
-
10.1186/1472-6904-6-1
- URN
-
urn:nbn:de:1111-2016072029959
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Levitt, David G.
- Schoemaker, Rik C.
- SpringerLink (Online service)
Other Objects (12)
Hämodynamische Untersuchungen an Typ-2-diabetischen Ratten : Einfluss des ACE-Inhibitors Ramipril
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
ACE inhibitors
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Effekte einer chronischen Behandlung mit dem ACE-Inhibitor Ramipril, dem ACE-NEP-Inhibitor AVE 7688 sowie in Kombination mit dem B2- Rezeptor-Antagonisten HOE 140 in adulten diabetischen und nichtdiabetischen Ratten
Einfluss des ACE-NEP-Inhibitors AVE 7688 und des ACE-Hemmers Ramipril auf die Mortalität von spontan hypertensiven Ratten unter besonderer Berücksichtigung der Gefäß-, Nieren- und Herzfunktion
Hämodynamische Untersuchungen an Typ-2-diabetischen Ratten : Einfluss des ACE-Inhibitors Ramipril
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
ACE inhibitors
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Effekte einer chronischen Behandlung mit dem ACE-Inhibitor Ramipril, dem ACE-NEP-Inhibitor AVE 7688 sowie in Kombination mit dem B2- Rezeptor-Antagonisten HOE 140 in adulten diabetischen und nichtdiabetischen Ratten
Einfluss des ACE-NEP-Inhibitors AVE 7688 und des ACE-Hemmers Ramipril auf die Mortalität von spontan hypertensiven Ratten unter besonderer Berücksichtigung der Gefäß-, Nieren- und Herzfunktion
Hämodynamische Untersuchungen an Typ-2-diabetischen Ratten : Einfluss des ACE-Inhibitors Ramipril
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
ACE inhibitors
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Effekte einer chronischen Behandlung mit dem ACE-Inhibitor Ramipril, dem ACE-NEP-Inhibitor AVE 7688 sowie in Kombination mit dem B2- Rezeptor-Antagonisten HOE 140 in adulten diabetischen und nichtdiabetischen Ratten